KYTX DCF Valuation - Kyverna Therapeutics Inc

K

Watchlist Manager

Watchlist

Price: 9.29 USD -0.75%

Market Cap: $530.7m

K	Kyverna Therapeutics Inc NASDAQ:KYTX	US
A	Astroscale Holdings Inc TSE:186A	JP
R	R S Software (India) Ltd BSE:517447	IN
	Herborium Group Inc OTC:HBRM	US
	Pharmacielo Ltd XTSX:PCLO	CA
M	Mito Securities Co Ltd TSE:8622	JP
	IG Port Inc TSE:3791	JP
	Nippon Prologis REIT Inc TSE:3283	JP
O	Oldfields Holdings Ltd ASX:OLH	AU
T	Tianjin Realty Development Group Co Ltd SSE:600322	CN
	Orchestra Holdings Inc TSE:6533	JP
G	GS P&L Co Ltd KRX:499790	KR
G	George Kent (Malaysia) Bhd KLSE:GKENT	MY
F	Fibra Mty SAPI de CV BMV:FMTY14	MX
I	Intloop Inc TSE:9556	JP
	Cassius Mining Ltd ASX:CMD	AU
	China Citic Bank Corp Ltd OTC:CHBJF	CN
D	Downer EDI Ltd NZX:DOW	AU
D	Direct Finance of Direct Group 2006 Ltd TASE:DIFI	IL
	Grupo Televisa SAB NYSE:TV	MX
	ProQR Therapeutics NV NASDAQ:PRQR	NL
	Orange Sky Golden Harvest Entertainment (Holdings) Ltd HKEX:1132	HK
	Intevac Inc NASDAQ:IVAC	US
	Livetiles Ltd ASX:LVT	AU

KYTX's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.